Year archive

Gentian Diagnostics ASA — 2026 filings

All 28 regulatory filings released by Gentian Diagnostics ASA (GENT) in 2026, sourced directly from the official regulator.

28 Filings

2026 Period

2026 filings (28)

Filing	Released	Lang
Flaggemelding Gentian Diagnostics Major Shareholding Notification	2026-05-13	Norwegian Bokmål
Meldepliktig handel og endring i styret - Attachment: Gentian - PCA attachment Vatne Capital AS.pdf Director's Dealing	2026-05-13	Norwegian Bokmål
Flaggemelding – Gentian Diagnostics ASA - Attachment: Flaggemelding.pdf Major Shareholding Notification	2026-05-13	Norwegian Bokmål
Meldepliktig handel og endring i styret Director's Dealing	2026-05-13	Norwegian Bokmål
Flaggemelding – Gentian Diagnostics ASA Major Shareholding Notification	2026-05-13	Norwegian Bokmål
Board resignation Board/Management Information	2026-05-13	English
Gentian Diagnostics: First quarter 2026 report - Attachment: GDASA Q1 26 presentation.pdf Regulatory Filings	2026-05-06	Norwegian
Gentian Diagnostics: First quarter 2026 report - Attachment: GDASA Interim report 1Q 2026.pdf Regulatory Filings	2026-05-06	Norwegian
Gentian Diagnostics: First quarter 2026 report Regulatory Filings	2026-05-06	Norwegian
Gentian Diagnostics ASA terminates NT-proBNP assay development Regulatory Filings	2026-05-06	Norwegian
Gentian Diagnostics: Ex dividend NOK 0.60 today Regulatory Filings	2026-05-06	Norwegian
Gentian Diagnostics: Minutes from Annual General Meeting - Attachment: GDASA AGM 2026 05 05 Minutes.pdf Regulatory Filings	2026-05-05	Norwegian
Gentian Diagnostics: Minutes from Annual General Meeting Regulatory Filings	2026-05-05	Norwegian
Gentian Diagnostics: Invitation to presentation of first quarter results Report Publication Announcement	2026-04-29	English
Gentian Diagnostics renews long-term faecal calprotectin partnership with Bühlmann Laboratories Regulatory Filings	2026-04-20	English
Gentian Diagnostics: Notice of annual general meeting - Attachment: GDASA AGM 2026 05 05.pdf Regulatory Filings	2026-04-13	Norwegian
Gentian Diagnostics: Notice of annual general meeting Proxy Solicitation & Information Statement	2026-04-13	English
Gentian Diagnostics ASA - Registration of share capital increase Share Issue/Capital Change	2026-04-10	English
Gentian Diagnostics: Annual report 2025 - Attachment: GDASA annual report 2025.pdf Annual Report FY 2025	2026-03-20	English
Gentian Diagnostics: Annual report 2025 - Attachment: 5967007LIEEXZXHNM861-2025-12-31-1-en.zip Annual Report (ESEF) FY 2025	2026-03-20	English
Gentian Diagnostics: Annual report 2025 Report Publication Announcement	2026-03-20	English
Gentian Diagnostics ASA – Mandatory notification of subscription of shares by primary insiders in Employee Share Purchase Program - Attachment: KRT1500_all.pdf Director's Dealing	2026-03-12	Norwegian
Gentian Diagnostics ASA – Mandatory notification of subscription of shares by primary insiders in Employee Share Purchase Program Director's Dealing	2026-03-12	English
Gentian Diagnostics ASA – Employee Share Purchase Program and share capital increase Share Issue/Capital Change	2026-03-12	English
Mandatory notification of trade - Attachment: 2026 02 19 Frank Frantzen KRT-1500.pdf Director's Dealing	2026-02-19	Norwegian
Mandatory notification of trade Director's Dealing	2026-02-19	English
Gentian Diagnostics: Invitation to presentation of fourth quarter results Report Publication Announcement	2026-02-04	English
Gentian Diagnostics invites to NT-proBNP educational webinar Regulatory Filings	2026-01-28	English

Filings by year

2026 28 filings
2025 56 filings
2024 39 filings
2023 48 filings
2022 52 filings
2021 54 filings
2020 47 filings
2019 48 filings
2018 42 filings
2017 40 filings
2016 12 filings